Internal Medicine, Nephrology · Tulsa, OK
NPI
1871706713
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
2000 S Wheeling Ave, Ste 510
Tulsa, OK, 74104
Phone (918) 660-3632
Groups this clinician bills Medicare through
Medicare paid, 2024
$259K
2,364 services
Medicare patients, 2024
657
Average age 72
Drug cost, 2024
$727K
2,657 prescriptions
Company payments, 2025
$1,167
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anand Khurana was code 90966 (esrd related services (not dialysis)), 455 times for 58 patients. In total Anand Khurana billed 2,364 services in 18 codes, and Medicare paid $259K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90966 ESRD Related Services (not dialysis) | Office | 455 | 58 | $207.18 | $94K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 330 | 206 | $11.80 | $3,895 |
| 99233 Hospital E&M - Subsequent | Facility | 285 | 135 | $87.41 | $25K |
| 99214 Office E&M - Established | Office | 283 | 164 | $47.45 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 263 | 113 | $57.16 | $15K |
| 90960 ESRD Related Services (not dialysis) | Office | 255 | 40 | $257.50 | $66K |
| 99213 Office E&M - Established | Office | 108 | 90 | $45.10 | $4,870 |
| 99214 Office E&M - Established | Facility | 105 | 52 | $67.95 | $7,135 |
| 99213 Office E&M - Established | Facility | 63 | 52 | $42.79 | $2,696 |
| 99223 Hospital E&M - Initial | Facility | 60 | 59 | $128.65 | $7,719 |
| 90961 ESRD Related Services (not dialysis) | Office | 44 | 28 | $208.74 | $9,185 |
| 99222 Hospital E&M - Initial | Facility | 26 | 26 | $89.19 | $2,319 |
| 99204 Office E&M - New | Office | 24 | 24 | $113.70 | $2,729 |
| 99204 Office E&M - New | Facility | 14 | 14 | $88.65 | $1,241 |
By year: 2022 $225K for 1,810 services; 2023 $224K for 1,750 services; 2024 $259K for 2,364 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anand Khurana prescribed most often to Medicare patients was Calcitriol, with 351 prescriptions and refills. In total Anand Khurana wrote 2,657 Medicare prescriptions that cost $727K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 351 | 629 | 86 | $5,828 |
| Amlodipine Besylate Generic | 183 | 362 | 57 | $1,541 |
| Farxiga Dapagliflozin Propanediol | 166 | 208 | 31 | $117K |
| Torsemide Generic | 119 | 299 | 47 | $3,788 |
| Sevelamer Carbonate Generic | 109 | 231 | 46 | $20K |
| Carvedilol Generic | 102 | 217 | 30 | $848 |
| Furosemide Generic | 93 | 197 | 37 | $562 |
| Doxazosin Mesylate Generic | 67 | 101 | 16 | $935 |
| Losartan Potassium Generic | 61 | 135 | 26 | $474 |
| Potassium Chloride Generic | 56 | 96 | 21 | $832 |
| Allopurinol Generic | 55 | 110 | 16 | $616 |
| Spironolactone Generic | 55 | 126 | 17 | $532 |
| Tamsulosin Hcl Generic | 53 | 93 | 15 | $667 |
| Lisinopril Generic | 52 | 106 | 18 | $299 |
| Cephalexin Generic | 45 | 45 | 39 | $185 |
Brand drugs: 457 claims; generic drugs: 2,200 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anand Khurana $1,167 ($1,167 in general payments such as food, travel and fees) from 18 companies. The largest payer was Amgen Inc. with $162.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 15 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $144 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $143 |
| Calliditas Therapeutics US Inc. | 4 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $81.68 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $75.09 |
| Merck Sharp & Dohme LLC MRK | 3 | $67.66 |
| Mallinckrodt Hospital Products Inc. | 2 | $59.41 |
| Travere Therapeutics, Inc. TVTX | 2 | $57.22 |
| Novo Nordisk Inc NVO | 2 | $52.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.